tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Syndax Pharmaceuticals Inc

SNDX
Add to Watchlist
18.070USD
+0.450+2.55%
Close 09-21 16:00（ET）
1.61BMarket Cap
LossP/E TTM

Syndax Pharmaceuticals Inc

18.070
+0.450+2.55%
Overview
Financials
Stock Score
Technical
Forecast
Ownership
Dividends
Profile
Discussions
Financial SummaryIncome StatementBalance SheetCash Flow StatementEarningsCompany ValuationRisk Assessment

Overview

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial SummaryIncome StatementBalance SheetCash Flow StatementEarningsCompany ValuationRisk Assessment

SNDX Financials

See Syndax Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
1.61B
Dividend TTM
0.00
P/E TTM
-6.46
EPS TTM
-2.79
Revenue
172.35M
Net Profit
-318.76M
ROE
-189.53%
ROA
-43.70%

Syndax Pharmaceuticals Inc Earnings Date

Latest Release
Aug 4, 2026
EPS / Forecast
-0.55/-0.44
Revenue / Forecast
72.79M/79.32M

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
33.34%-0.55
50.89%-0.48
28.06%-0.78
28.82%-0.70
-4.26%-0.83
-15.89%-0.98
-8.89%-1.09
-34.49%-0.98
-24.58%-0.80
-43.46%-0.85
-61.14%-1.00
---0.73
---0.64
---0.59
---0.62
---1.84
----
----
----
----
Revenue
91.76%72.79M
223.64%64.86M
794.90%68.73M
266.97%45.87M
984.51%37.96M
--20.04M
--7.68M
--12.50M
--3.50M
--0.00
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
33297.36%126.58M
3165.17%12.38M
Net Profit
31.29%-49.36M
49.71%-42.67M
27.77%-68.01M
27.83%-60.72M
-5.56%-71.85M
-17.19%-84.85M
-29.94%-94.17M
-64.48%-84.13M
-52.56%-68.06M
-76.04%-72.40M
-84.91%-72.47M
-44.47%-51.15M
-18.75%-44.62M
-10.65%-41.13M
-140.74%-39.19M
-71.53%-35.40M
-64.00%-37.57M
-34.07%-37.17M
571.03%96.20M
-0.99%-20.64M
Net Margin
64.17%-67.82%
84.46%-65.79%
91.93%-98.96%
80.33%-132.36%
90.27%-189.28%
---423.34%
---1226.16%
---673.01%
---1944.66%
----
----
----
----
----
----
----
----
----
----
----
Gross Margin
-1.07%95.59%
0.37%95.94%
7.64%96.06%
-4.58%95.42%
-3.37%96.63%
--95.58%
--89.24%
--100.00%
--100.00%
----
----
----
----
----
----
----
----
----
----
----
Debt to assets ratio
44.35%83.58%
35.05%72.77%
36.92%64.92%
2210055.32%62.33%
1728301.79%57.90%
1539507.14%53.89%
1320723.12%47.42%
-53.08%0.00%
-46.49%0.00%
-5.41%0.00%
-0.83%0.00%
--0.01%
--0.01%
--0.00%
--0.00%
--0.01%
----
----
----
----
Income Statement
Revenue
91.76%72.79M
223.64%64.86M
794.90%68.73M
266.97%45.87M
984.51%37.96M
--20.04M
--7.68M
--12.50M
--3.50M
--0.00
--0.00
--0.00
--0.00
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
33297.36%126.58M
3165.17%12.38M
Operating profit
42.33%-39.99M
59.04%-34.20M
35.09%-62.55M
35.89%-57.43M
6.55%-69.35M
-5.03%-83.51M
-23.70%-96.36M
-58.95%-89.58M
-49.39%-74.22M
-72.80%-79.51M
-85.34%-77.91M
-60.37%-56.35M
-31.69%-49.68M
-24.84%-46.02M
-143.90%-42.03M
-75.42%-35.14M
-68.91%-37.72M
-35.69%-36.86M
582.10%95.75M
-0.90%-20.03M
Net Profit
31.29%-49.36M
49.71%-42.67M
27.77%-68.01M
27.83%-60.72M
-5.56%-71.85M
-17.19%-84.85M
-29.94%-94.17M
-64.48%-84.13M
-52.56%-68.06M
-76.04%-72.40M
-84.91%-72.47M
-44.47%-51.15M
-18.75%-44.62M
-10.65%-41.13M
-140.74%-39.19M
-71.53%-35.40M
-64.00%-37.57M
-34.07%-37.17M
571.03%96.20M
-0.99%-20.64M
Balance Sheet
Current assets
26.96%675.04M
-14.14%471.18M
-12.43%528.08M
27.73%529.83M
19.19%531.68M
20.90%548.75M
3.82%603.06M
8.88%414.81M
9.04%446.06M
2.81%453.90M
18.60%580.88M
6.53%380.97M
4.28%409.08M
5.11%441.51M
9.23%489.79M
50.11%357.63M
49.41%392.29M
50.59%420.06M
50.03%448.40M
34.28%238.25M
Total current liabilities
-11.78%99.68M
-8.86%86.17M
16.00%120.12M
92.31%114.19M
166.03%112.99M
86.11%94.55M
78.24%103.55M
51.57%59.38M
40.78%42.47M
114.18%50.80M
99.88%58.10M
88.31%39.17M
-2.45%30.17M
-22.36%23.72M
40.53%29.07M
-27.55%20.80M
27.31%30.93M
24.35%30.55M
9.60%20.68M
89.43%28.71M
Total assets
18.03%703.65M
-26.23%472.67M
-26.92%529.71M
29.59%551.79M
24.99%596.15M
17.99%640.71M
18.26%724.82M
6.66%425.81M
10.57%476.95M
18.09%543.03M
23.26%612.88M
10.99%399.22M
6.13%431.34M
8.91%459.83M
10.58%497.24M
50.18%359.69M
54.50%406.44M
50.97%422.22M
49.58%449.66M
33.57%239.50M
Total liabilities
56.94%688.55M
1.27%431.05M
6.50%465.08M
634.88%436.36M
929.65%438.73M
732.34%425.65M
644.14%436.69M
48.31%59.38M
36.14%42.61M
110.27%51.14M
97.01%58.68M
85.49%40.04M
-29.66%31.30M
-48.98%24.32M
-27.86%29.79M
-46.70%21.59M
-8.25%44.50M
-7.37%47.67M
-14.74%41.29M
-14.44%40.50M
Total equity
-90.41%15.10M
-80.65%41.62M
-77.57%64.63M
-68.50%115.43M
-63.76%157.42M
-56.28%215.06M
-48.01%288.12M
2.02%366.43M
8.57%434.34M
12.95%491.89M
18.56%554.20M
6.24%359.19M
10.53%400.04M
16.27%435.50M
14.47%467.45M
69.90%338.10M
68.69%361.94M
64.13%374.55M
61.93%408.37M
50.79%199.00M
Cash Flow Statement
Net operating income
65.52%-30.27M
47.10%-50.34M
-21.08%-69.49M
-13.18%-70.53M
-22.54%-87.80M
-13.90%-95.16M
-38.79%-57.39M
-39.57%-62.32M
-102.55%-71.64M
-112.98%-83.55M
-80.61%-41.35M
-56.44%-44.65M
12.24%-35.37M
6.45%-39.23M
-122.73%-22.89M
-14.43%-28.54M
-67.63%-40.31M
-85.63%-41.93M
744.29%100.71M
-36.33%-24.94M
Net investment
-140.38%-16.91M
-59.22%38.39M
130.33%81.58M
-16.60%72.43M
-32.17%41.89M
194.71%94.14M
-1551.15%-268.97M
116.70%86.85M
-16.45%61.75M
-599.12%-99.40M
88.16%-16.29M
689.97%40.08M
247.97%73.91M
143.40%19.91M
-129.55%-137.63M
-125.51%-6.79M
-330.39%-49.95M
127.99%8.18M
6.52%-59.96M
38.16%26.63M
Net financing
45774.77%252.77M
751.40%7.92M
-98.30%5.92M
102.65%6.28M
-18.49%551.00K
-57.10%930.00K
34.41%347.43M
67.37%3.10M
-48.94%676.00K
-12.37%2.17M
58.09%258.48M
113.69%1.85M
-93.90%1.32M
344.17%2.47M
48.94%163.50M
-893.26%-13.53M
260.80%21.72M
-41.98%557.00K
-20.83%109.78M
-3.51%1.71M

FAQs

What is the total revenue of Syndax Pharmaceuticals Inc?

According to Syndax Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 172.35M, with a year-on-year change of 23.68M.

What are the current assets of Syndax Pharmaceuticals Inc?

According to Syndax Pharmaceuticals Inc's FY2025 earnings report, its current assets were 528.08M, with a year-on-year change of -12.43.

What are the total assets of Syndax Pharmaceuticals Inc?

According to Syndax Pharmaceuticals Inc's FY2025 earnings report, its total assets of Syndax Pharmaceuticals Inc were 529.71M, with a year-on-year change of -26.92.

What are the total liabilities of Syndax Pharmaceuticals Inc?

According to Syndax Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Syndax Pharmaceuticals Inc were 465.08M, with a year-on-year change of 6.50.

What is the total equity of Syndax Pharmaceuticals Inc?

According to Syndax Pharmaceuticals Inc's FY2025 earnings report, its total equity of Syndax Pharmaceuticals Inc was 64.63M, with a year-on-year change of -77.57.

What is the net operating income of Syndax Pharmaceuticals Inc?

According to Syndax Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Syndax Pharmaceuticals Inc was -273.08M, with a year-on-year change of 19.60.

What is the net investment of Syndax Pharmaceuticals Inc?

According to Syndax Pharmaceuticals Inc's FY2025 earnings report, its net investment of Syndax Pharmaceuticals Inc was 290.04M, with a year-on-year change of 231.97.

What is the net financing of Syndax Pharmaceuticals Inc?

According to Syndax Pharmaceuticals Inc's FY2025 earnings report, its net financing of Syndax Pharmaceuticals Inc was 13.68M, with a year-on-year change of -96.13.

What is the Earnings Per Share (EPS) of Syndax Pharmaceuticals Inc?

According to Syndax Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -3.29, with a year-on-year change of 11.50.

What is the net income of Syndax Pharmaceuticals Inc?

According to Syndax Pharmaceuticals Inc's FY2025 earnings report, its net income was -285.42M, with a year-on-year change of 10.46.

What is the net margin of Syndax Pharmaceuticals Inc?

According to Syndax Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was -165.60, with a year-on-year change of 87.70.

What is the gross margin of Syndax Pharmaceuticals Inc?

According to Syndax Pharmaceuticals Inc's FY2025 earnings report, its gross margin was 95.96, with a year-on-year change of -0.58.

What is the debt-to-asset ratio of Syndax Pharmaceuticals Inc?

According to Syndax Pharmaceuticals Inc's FY2025 earnings report, its debt-to-asset ratio was 64.92, with a year-on-year change of 36.92.

What is the Return on Equity (ROE) of Syndax Pharmaceuticals Inc?

According to Syndax Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -161.82, with a year-on-year change of -113.81.

What is the Return on Assets (ROA) of Syndax Pharmaceuticals Inc?

According to Syndax Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -45.50, with a year-on-year change of 4.52.

What is the operating profit of Syndax Pharmaceuticals Inc?

According to Syndax Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -273.08M, with a year-on-year change of 19.60.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy